Optimizing MDS Management: Key Takeaways from the COMMANDS Trial

Thomas LeBlanc, MD, MA, of Duke Cancer Institute; Andrew Brunner, MD, of Massachusetts General Hospital; and Jamie Koprivnikar, MD, of Hackensack University Medical Center, discuss the COMMANDS trial and sequencing luspatercept in patients with myelodysplastic syndromes.